Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antihypertensive Therapy for Mild Chronic Hypertension During Pregnancy (CHAP)
NCT02299414Phase 4Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Jun 2015
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of labetalol, nifedipine in hypertension (HTN), sponsored by University of Alabama at Birmingham. Started Jun 2015; status: completed.
02
Drugs
labetalolnifedipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02299414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02299414.